Skip to main content
. 2021 Jul 9;13(7):2350. doi: 10.3390/nu13072350

Table 2.

Measurements of muscle mass and PG-SGA SF.

All Patients (n = 49) Men (n = 26) Women (n = 23)
CTSMI (mean ± SD) 45.5 ± 13.4 43.3 ± 12.4 47.8 ± 14.3
  Low muscle mass (n, %) 23 (46.9) 15 (57.7) 8 (34.8)
Missing: 1 Missing: 1
CTPMI (median, IQR) 58.0 (50.0–71.0) 69.5 (56.5–83.0) 53.0 (44.0–59.0)
  Low muscle mass (n, %) 13 (26.5) 7 (26.9) 6 (26.1)
BIAFFMI (mean ± SD) 18.8 ± 2.8 20.6 ± 2.1 16.7 ± 1.7
  Low muscle mass (n, %) 5 (10.2) 3 (11.5) 2 (8.7)
BIAASMI (mean ± SD) 7.0 ± 1.2 7.7 ± 0.9 6.2 ± 0.9
  Low muscle mass (n, %) 10 (20.4) 5 (19.2) 5 (21.7)
Missing: 1 Missing: 1
MAMC (mean ± SD) 25.2 ± 4.7 26.7 ± 4.9 23.4 ± 3.7
  Low muscle mass (n, %) 9 (18.4) 5 (19.2) 4 (17.4)
PG-SGA SF score (median, IQR) 3.0 (0.0–7.0) 1.0 (0.0–6.8) 3.0 (1.0–6.0)
  4 points (n, %) 20 (40.8) 11 (42.3) 9 (39.1)
  9 points (n, %) 8 (16.3) 4 (15.4) 4 (17.4)

CT, computed tomography; SMI, skeletal muscle index (cm2/m2); PMI, psoas muscle index (mm2/m2); BIA, bioelectrical impedance analysis; FFMI, fat free mass index (kg/m2); ASMI, appendicular skeletal muscle index (kg/m2); MAMC, mid-upper arm muscle circumference (cm); PG-SGA SF, patient generated-subjective global assessment short form (points).